302 related articles for article (PubMed ID: 16871272)
21. Impact of tadalafil once daily in men with erectile dysfunction--including a report of the partners' evaluation.
Althof SE; Rubio-Aurioles E; Kingsberg S; Zeigler H; Wong DG; Burns P
Urology; 2010 Jun; 75(6):1358-63. PubMed ID: 20206967
[TBL] [Abstract][Full Text] [Related]
22. An evaluation of semen characteristics in men 45 years of age or older after daily dosing with tadalafil 20mg: results of a multicenter, randomized, double-blind, placebo-controlled, 9-month study.
Hellstrom WJ; Gittelman M; Jarow J; Steidle C; McMurray J; Talley D; Watts S; Mitchell CL; McGill JM
Eur Urol; 2008 May; 53(5):1058-65. PubMed ID: 17945409
[TBL] [Abstract][Full Text] [Related]
23. The efficacy of tadalafil in improving sexual satisfaction and overall satisfaction in men with mild, moderate, and severe erectile dysfunction: a retrospective pooled analysis of data from randomized, placebo-controlled clinical trials.
Rosen RC; Shabsigh R; Kuritzky L; Wang WC; Sides GD
Curr Med Res Opin; 2005 Nov; 21(11):1701-9. PubMed ID: 16307689
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial.
Porst H; Kim ED; Casabé AR; Mirone V; Secrest RJ; Xu L; Sundin DP; Viktrup L;
Eur Urol; 2011 Nov; 60(5):1105-13. PubMed ID: 21871706
[TBL] [Abstract][Full Text] [Related]
25. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A
BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
[TBL] [Abstract][Full Text] [Related]
26. Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studies.
Porst H; Gacci M; Büttner H; Henneges C; Boess F
Eur Urol; 2014 Feb; 65(2):455-64. PubMed ID: 24119319
[TBL] [Abstract][Full Text] [Related]
27. A randomized, double-blind, placebo-controlled, parallel study to assess the efficacy and safety of once-a-day tadalafil in men with erectile dysfunction who are naïve to PDE5 inhibitors.
Montorsi F; Aversa A; Moncada I; Perimenis P; Porst H; Barker C; Shane MA; Sorsaburu S
J Sex Med; 2011 Sep; 8(9):2617-24. PubMed ID: 21707928
[TBL] [Abstract][Full Text] [Related]
28. Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction.
Montorsi F; Verheyden B; Meuleman E; Jünemann KP; Moncada I; Valiquette L; Casabé A; Pacheco C; Denne J; Knight J; Segal S; Watkins VS
Eur Urol; 2004 Mar; 45(3):339-44; discussion 344-5. PubMed ID: 15036680
[TBL] [Abstract][Full Text] [Related]
29. Tolerance to the therapeutic effect of tadalafil does not occur during 6 months of treatment: A randomized, double-blind, placebo-controlled study in men with erectile dysfunction.
McMahon CG; Carson CC; Fischer CJ; Wang WC; Florio VA; Bradley JD
J Sex Med; 2006 May; 3(3):504-11. PubMed ID: 16681476
[TBL] [Abstract][Full Text] [Related]
30. On-demand IC351 (Cialis) enhances erectile function in patients with erectile dysfunction.
Padma-Nathan H; McMurray JG; Pullman WE; Whitaker JS; Saoud JB; Ferguson KM; Rosen RC;
Int J Impot Res; 2001 Feb; 13(1):2-9. PubMed ID: 11313831
[TBL] [Abstract][Full Text] [Related]
31. Time from dosing to sexual intercourse attempts in men taking tadalafil in clinical trials.
Shabsigh R; Burnett AL; Eardley I; Sharlip ID; Ellsworth PI; Garcia CS; Natanegara F; Ahuja S
BJU Int; 2005 Oct; 96(6):857-63. PubMed ID: 16153217
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of tadalafil in the treatment of erectile dysfunction in hypertensive men on concomitant thiazide diuretic therapy.
Kloner RA; Sadovsky R; Johnson EG; Mo D; Ahuja S
Int J Impot Res; 2005; 17(5):450-4. PubMed ID: 16015377
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of on-demand oral tadalafil in the treatment of men with erectile dysfunction in Taiwan: a randomized, double-blind, parallel, placebo-controlled clinical study.
Chen KK; Jiann BP; Lin JS; Lee SS; Huang ST; Wang CJ; Ju-Ton H; Su CK; Costigan TM; Emmick JT
J Sex Med; 2004 Sep; 1(2):201-8. PubMed ID: 16422975
[TBL] [Abstract][Full Text] [Related]
34. Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT).
Montorsi F; Brock G; Stolzenburg JU; Mulhall J; Moncada I; Patel HR; Chevallier D; Krajka K; Henneges C; Dickson R; Büttner H
Eur Urol; 2014 Mar; 65(3):587-96. PubMed ID: 24169081
[TBL] [Abstract][Full Text] [Related]
35. Improvements in confidence, sexual relationship and satisfaction measures: results of a randomized trial of tadalafil 5 mg taken once daily.
Seftel AD; Buvat J; Althof SE; McMurray JG; Zeigler HL; Burns PR; Wong DG
Int J Impot Res; 2009; 21(4):240-8. PubMed ID: 19536128
[TBL] [Abstract][Full Text] [Related]
36. The influence of age on treatment outcomes in men with erectile dysfunction treated with two regimens of tadalafil: results of the SURE study.
Wespes E; Moncada I; Schmitt H; Jungwirth A; Chan M; Varanese L
BJU Int; 2007 Jan; 99(1):121-6. PubMed ID: 17227498
[TBL] [Abstract][Full Text] [Related]
37. Reliability of efficacy in men with erectile dysfunction treated with tadalafil once daily after initial success.
Shabsigh R; Donatucci C; Costabile R; Perelman MA; Burns P; Zeigler H; Wong DG
Int J Impot Res; 2010; 22(1):1-8. PubMed ID: 19657349
[TBL] [Abstract][Full Text] [Related]
38. Efficacy, tolerability and satisfaction with sildenafil citrate 100-mg titration compared with continued 50-mg dose treatment in men with erectile dysfunction.
Buvat J; Hatzichristou D; Maggi M; Farmer I; Martínez-Jabaloyas JM; Miller PJ; Schnetzler G
BJU Int; 2008 Dec; 102(11):1645-50. PubMed ID: 18710446
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of oral SK3530 for the treatment of erectile dysfunction in Korean men: a multicenter, randomized, double-blind, placebo-controlled, fixed dose, parallel group clinical trial.
Paick JS; Choi HK; Kim SC; Ahn TY; Kim JJ; Park JK; Park KS; Lee SW; Kim SW; Park K; Jung H; Park NC
Asian J Androl; 2008 Sep; 10(5):791-8. PubMed ID: 18645683
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of oral tadalafil in the treatment of men in Canada with erectile dysfunction: a randomized, double-blind, parallel, placebo-controlled clinical trial.
Carrier S; Brock GB; Pommerville PJ; Shin J; Anglin G; Whitaker S; Beasley CM
J Sex Med; 2005 Sep; 2(5):685-98. PubMed ID: 16422827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
